Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Champions Oncolog
(NQ:
CSBR
)
4.560
+0.020 (+0.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Champions Oncolog
< Previous
1
2
Next >
Champions Oncology Announces Agreement with Weill Cornell Medicine
October 16, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
September 11, 2024
Via
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
September 09, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $14.0 Million
July 18, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
July 11, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $13.1 Million
July 24, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Via
ACCESSWIRE
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
June 04, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.0 Million
March 12, 2024
Via
ACCESSWIRE
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
March 07, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
March 06, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $11.6 Million
December 12, 2023
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
December 04, 2023
Via
ACCESSWIRE
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
November 02, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
October 17, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.6 Million
September 13, 2023
Via
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
September 11, 2023
Via
ACCESSWIRE
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
August 22, 2023
Via
ACCESSWIRE
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
August 01, 2023
Via
ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
July 20, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development
April 17, 2023
Via
ACCESSWIRE
Champions Oncology Announces $5M Stock Repurchase Program
April 05, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.8 Million
March 15, 2023
Via
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
March 13, 2023
Via
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
December 13, 2022
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
December 09, 2022
Via
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 08, 2022
Via
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
September 06, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Record Annual Revenue of $49.1 Million
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit